Systematic Review
Accepted on 17 Feb 2026
Immune checkpoint inhibitor-associated bullous pemphigoid: a systematic review of clinical characteristics and outcomes based on case reports
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Type at least 3 characters
9,627 articles
articles
Original Research
Published on 17 Feb 2026
ctDNA guided management of POLE mutant GI malignancies promotes exceptional responses and prolonged survival to immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1738295
Correction
Published on 17 Feb 2026
Correction: FGA modulates immune infiltration and tumor progression via SLC7A11/xCT-mediated disulfidptosis in the tumor microenvironment of lung adenocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1789896
Original Research
Published on 17 Feb 2026
Evaluation of six clinical prognostic scores in NSCLC patients undergoing first line chemoimmunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1695859
- 120 views
Original Research
Published on 17 Feb 2026
CircNF1 promotes gastric cancer metastasis by stabilizing HMGA2 mRNA through IGF2BP1 interaction
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1767319
- 232 views
Original Research
Published on 17 Feb 2026
Integrating computational engines to identify TSPAN6 as a migrasome-associated target for immunotherapy sensitization
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1782717
Original Research
Published on 17 Feb 2026
Chlorpromazine activates cGAS-STING signaling and reprograms the immune response in glioblastoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1743232
- 128 views
Original Research
Published on 17 Feb 2026
Unraveling the role of LINC02657 in clear cell renal cell carcinoma: insights into tumor aggression, immune modulation, and treatment response
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1735169
Case Report
Published on 17 Feb 2026
Case Report: A case of superficial spreading malignant melanoma with sentinel lymph node metastasis misdiagnosed as “pigmented nevus”
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1709633
Original Research
Published on 17 Feb 2026
Hepatic arterial infusion chemotherapy combined with apatinib plus camrelizumab for advanced hepatocellular carcinoma with type Vp4 portal vein tumor thrombosis: a multicenter propensity score-matching analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1742116
- 170 views
Original Research
Published on 17 Feb 2026
Mass spectrometry-based multi-omics analysis elucidates immune microenvironmental characteristics and the risk of distant metastasis in N1c colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2026.1590042
- 171 views
Original Research
Accepted on 16 Feb 2026
Restoration of Melatonin Rhythms Reduces Tumor-Promoting Inflammation in Esophageal Cancer Survivors: A prospective cohort study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
General Commentary
Accepted on 16 Feb 2026
Mechanisms of Intravascular Immune Evasion in the Lung: Niche-Adaptive Mechanisms in Metastatic Breast Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 16 Feb 2026
ADAMTS9-AS2 acts as an epigenetic brake to constrain DNMT3B-mediated CADM2 silencing in esophageal squamous cell carcinoma metastasis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 16 Feb 2026
Effect of co-occurring mutations in TP53 gene and TERT promoter on the survival of bladder cancer patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 16 Feb 2026
AGR2 promotes tumor progression by regulating macrophage polarization via the CD98hc-xCT/p-ERK pathway
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Review
Accepted on 16 Feb 2026
Dual PD-1 and CTLA-4 Targeting in Endometrial Carcinoma: Integrating Efficacy, Toxicity, and Biomarkers into Clinical Practice
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Review
Accepted on 16 Feb 2026
Overcoming Heterogeneity and Immunosuppression: Novel Strategies in Adoptive Therapy for Biliary Tract Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 16 Feb 2026
A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Case Report
Accepted on 16 Feb 2026
Immune Checkpoint Inhibitor-Related Encephalitis Overlapping with Hyperprogression in Metastatic Lung Cancer: A Case Report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 16 Feb 2026
The Capability of Deep-radiomics to Predict Pathological Response to Neoadjuvant Immunochemotherapy in Non–small Cell Lung Cancer: A Retrospective Multicenter Study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 16 Feb 2026
TRP channel expression patterns define molecular subtypes, prognosis, and therapeutic targets in gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Review
Accepted on 16 Feb 2026
Spatiotemporal Control of Immunogenic Cell Death: Rewiring Tumor-Immune Dialogues for Next-Generation Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 16 Feb 2026
Analyses on patterns of lymph node metastasis and its impact on prognosis in thoracic esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy versus chemotherapy alone: A single-center, retrospective cohort study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology